| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 140.137 | 270.495 | 232.890 |
| Total Income - EUR | - | - | - | - | - | - | - | 140.176 | 270.621 | 233.908 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 74.571 | 105.166 | 136.402 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 65.605 | 165.455 | 97.507 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 64.070 | 163.377 | 90.649 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Gentech Innovations S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 9.856 | 103.476 | 84.291 |
| Current Assets | - | - | - | - | - | - | - | 62.516 | 217.648 | 150.858 |
| Inventories | - | - | - | - | - | - | - | 148 | 25 | 48 |
| Receivables | - | - | - | - | - | - | - | 59.819 | 202.866 | 115.862 |
| Cash | - | - | - | - | - | - | - | 2.548 | 14.758 | 34.947 |
| Shareholders Funds | - | - | - | - | - | - | - | 64.110 | 163.612 | 90.710 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 8.262 | 157.513 | 144.438 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Gentech Innovations S.r.l.